Silence Therapeutics plc Stock
Stocks
SLN
US82686Q1013
Biotechnology & Medical Research
OTC Markets Traded|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.535 USD | -6.06% |
|
-9.19% | +56.83% |
| Market Cap | 358M 479M 420M 388M 679M 45.86B 693M 4.66B 1.81B 22.44B 1.8B 1.76B 77.9B | P/E 2026 * |
-17x | P/E 2027 * | -15.1x |
|---|---|---|---|---|---|
| Enterprise Value | 212M 283M 248M 229M 402M 27.12B 410M 2.76B 1.07B 13.27B 1.06B 1.04B 46.07B | EV / Sales 2026 * |
84.9x | EV / Sales 2027 * | 31.7x |
| Free-Float |
69.36% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Silence Therapeutics plc
| 1 day | -6.06% | ||
| 1 week | -9.19% | ||
| Current month | -13.16% | ||
| 1 month | +53.05% | ||
| 3 months | +62.99% | ||
| 6 months | +64.40% | ||
| Current year | +56.83% |
| 1 week | 9.42 |  | 11.06 |
| 1 month | 5.88 | | 11.06 |
| Current year | 4.19 | | 11.06 |
| 1 year | 4.19 | | 11.06 |
| 3 years | 1.97 | | 27.72 |
| 5 years | 1.97 | | 27.72 |
| 10 years | 1.97 | | 35 |
| Manager | Title | Age | Since |
|---|---|---|---|
Iain Ross
CEO | Chief Executive Officer | 72 | 14/12/2025 |
Rhonda Hellums
DFI | Director of Finance/CFO | 54 | 21/02/2022 |
Curtis Rambaran
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
David Lemus
BRD | Director/Board Member | 63 | 21/06/2018 |
Iain Ross
CHM | Chairman | 72 | 01/12/2019 |
Rhonda Hellums
BRD | Director/Board Member | 54 | 18/12/2025 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 01-02 | Free | Director | 90,000 | 0.0635% | ||
| 01-02 | Free | Director | 90,000 | 0.0635% | ||
| 01-02 | Free | Chief Financial Officer | 375,000 | 0.2646% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -6.06% | -9.19% | +61.34% | +59.45% | 479M | |
| -0.24% | +1.85% | +3.13% | +8.40% | 49.74B | |
| -0.82% | +0.39% | +416.60% | +591.84% | 40.49B | |
| -3.14% | +3.13% | +22.65% | +55.74% | 34.35B | |
| -2.97% | -0.61% | +22.80% | -7.96% | 34.75B | |
| -0.79% | +2.02% | +3.83% | +36.42% | 26.98B | |
| +3.02% | +2.65% | - | - | 16.58B | |
| -4.26% | -3.62% | +62.44% | +116.67% | 15.6B | |
| -2.35% | +6.14% | +103.33% | +101.18% | 14.27B | |
| -2.70% | -2.04% | +12.37% | +17.77% | 13.76B | |
| Average | -2.15% | +2.83% | +78.72% | +108.83% | 24.7B | |
| Weighted average by Cap. | -1.74% | +4.34% | +92.64% | +132.53% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.5M 3.33M 2.92M 2.7M 4.73M 319M 4.82M 32.46M 12.61M 156M 12.52M 12.25M 542M | 3.44M 4.6M 4.03M 3.72M 6.52M 440M 6.65M 44.76M 17.39M 215M 17.27M 16.89M 748M |
| Net income | -50.34M -67.27M -59.01M -54.48M -95.41M -6.44B -97.32M -655M -254M -3.15B -253M -247M -10.94B | -84.67M -113M -99.24M -91.62M -160M -10.83B -164M -1.1B -428M -5.3B -425M -416M -18.4B |
| Net Debt | -146M -196M -172M -158M -278M -18.74B -283M -1.91B -740M -9.17B -735M -719M -31.83B | -249M -333M -292M -270M -473M -31.92B -482M -3.24B -1.26B -15.62B -1.25B -1.22B -54.22B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 08/07/26 | $9.550 | -5.91% | 102,958 |
| 07/07/26 | $10.15 | -4.06% | 617,739 |
| 06/07/26 | $10.58 | +1.83% | 578,918 |
| 02/07/26 | $10.39 | -1.05% | 696,727 |
| 01/07/26 | $10.50 | -4.37% | 718,986 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SLN Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
